Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local… — Class II drug recall D-0918-2018
Terminated recall by SCA Pharmaceuticals, reported 2018-07-18. Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
| Recall number | D-0918-2018 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SCA Pharmaceuticals, Little Rock, AR, United States |
| Recall initiated | 2018-06-29 |
| Classified | 2018-07-12 |
| Reported by FDA | 2018-07-18 |
| Terminated | 2019-05-01 |
| Quantity | 3,984 syringes |
| Reason classes | potency, specification failure |
| Expiration dates | 2018-07-01, 2018-07-05, 2018-07-12, 2018-07-25, 2018-07-26 |
Product
Buffered Lidocaine 1% with Sodium Bicarbonate Injection for Local Anesthetic Use (Concentration=10 mg/mL) 0.25 mL Total Volume, Rx only , SCA Pharmaceuticals, 8821 Knoedl Ct. Little Rock, AR 72205 877-550-5059
Reason for recall
Subpotent Drug: Stability data does not support the current expiration dating of 55 days after compounding.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0918-2018. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.